Gene therapy for lipoprotein lipase deficiency
Current Opinion in Lipidology, 08/03/2012
Gaudet D et al. – The overall benefit–risk ratio of associated viral vector (AAV)–LPLS447X gene therapy appears positive to date, particularly for the patients presenting the highest risk of complications.



